|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/18 | (2006.01) |
| C07K 14/50 | (2006.01) | ||
| A61K 38/00 | (2006.01) |
| (11) | Number of the document | 3248610 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17167682.8 |
| Date of filing the European patent application | 2010-05-04 | |
| (97) | Date of publication of the European application | 2017-11-29 |
| (45) | Date of publication and mention of the grant of the patent | 2023-12-20 |
| (46) | Date of publication of the claims translation | 2024-01-25 |
| (30) | Number | Date | Country code |
| 175736 P | 2009-05-05 | US | |
| 285118 P | 2009-12-09 | US |
| (72) |
BELOUSKI, Edward John , US
ELLISON, Murielle Marie , US
HAMBURGER, Agnes Eva , US
HECHT, Randy Ira , US
LI, Yue-Sheng , US
MICHAELS, Mark Leo , US
SUN, Jeonghoon , US
XU, Jing , US
|
| (73) |
Amgen Inc. ,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | FGF21 mutantai ir jų panaudojimas |
| FGF21 MUTANTS AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-04-02 | 16 | 347.00 EUR |
| 2026-05-04 |